HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intraocular lens implantation versus no intraocular lens implantation in patients with chronic iridocyclitis and pars planitis. A randomized prospective study.

AbstractPURPOSE:
The authors studied the safety of intraocular lens (IOL) implantation in patients with uveitis.
METHODS:
The authors prospectively randomized 26 patients with chronic iridocyclitis (22 patients) or pars planitis (4 patients) to undergo IOL implantation or no IOL implantation at the time of cataract surgery.
RESULTS:
There was no statistical difference in visual acuity results at 1 year between the two groups. There was a trend toward better visual acuity in patients with chronic iridocyclitis without IOLs. Cocoon-like dense fibrous membranes enveloped the IOL in two patients.
CONCLUSION:
The authors conclude that IOLs are relatively safe in patients with chronic iridocyclitis but that only a much larger study could determine if the trend toward better visual acuity without an IOL was real.
AuthorsH H Tessler, M D Farber
JournalOphthalmology (Ophthalmology) Vol. 100 Issue 8 Pg. 1206-9 (Aug 1993) ISSN: 0161-6420 [Print] United States
PMID8341503 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Chronic Disease
  • Contraindications
  • Female
  • Humans
  • Iridocyclitis (complications, etiology, surgery)
  • Lenses, Intraocular (adverse effects)
  • Macular Edema (etiology)
  • Male
  • Middle Aged
  • Pars Planitis (complications, surgery)
  • Postoperative Complications
  • Prospective Studies
  • Sarcoidosis (complications)
  • Treatment Outcome
  • Visual Acuity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: